Furthermore, through a comprehensive examination of three drug-resistant GC datasets in the GEO database, we discerned that Fra-1 expression was prevalent in chemotherapy-resistant GC [Figure 1C], suggesting a potential link between Fra-1 and chemotherapy resistance in GC. Here, FOSL1 is linked to gastric cancer.